These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3528320)

  • 1. Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
    Chadwick EG; Shulman ST; Yogev R
    J Infect Dis; 1986 Oct; 154(4):670-5. PubMed ID: 3528320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
    Moody JA; Fasching CE; Peterson LR; Gerding DN
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):59-67. PubMed ID: 3100127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
    Johnson DE; Calia FM; Snyder MJ; Warren JW; Schimpff SC
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():89-96. PubMed ID: 6583199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
    Wade JC; Standiford HC; Drusano GL; Johnson DE; Moody MR; Bustamante CI; Joshi JH; deJongh C; Schimpff SC
    Am J Med; 1985 Jun; 78(6A):62-72. PubMed ID: 3859217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amikacin therapy of infections in neutropenic patients.
    Valdivieso M; Feld R; Rodriguez V; Bodey GP
    Am J Med Sci; 1975; 270(3):453-63. PubMed ID: 1108649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antibiotic therapy in pediatrics.
    Chadwick EG; Yogev R; Shulman ST
    Am J Med; 1986 Jun; 80(6B):166-71. PubMed ID: 3728528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pediatric infections with amikacin as first-line aminoglycoside.
    Shulman ST; Yogev R
    Am J Med; 1985 Jul; 79(1A):43-50. PubMed ID: 4025367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
    Martino P; Venditti M; Petti MC; Mandelli F; Serra P
    Infection; 1985; 13(3):125-9. PubMed ID: 3928495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy of septicemia due to Klebsiella pneumoniae in neutropenic rats.
    Winston DJ; Sidell J; Hairston J; Young LS
    J Infect Dis; 1979 Apr; 139(4):377-88. PubMed ID: 374646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Peterson LR; Gerding DN; Moody JA; Fasching CE
    Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
    Gerding DN; Peterson LR; Moody JA; Fasching CE
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():207-19. PubMed ID: 3856563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
    Shyu WC; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin therapy for serious gram-negative infection.
    Pollock AA; Berger SA; Richmond AS; Simberkoff MS; Rahal JJ
    JAMA; 1977 Feb; 237(6):562-4. PubMed ID: 576282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
    Tally FP; Louie TJ; O'Keefe P; Gorbach SL; Bartlett JG
    J Infect Dis; 1976 Nov; 134 SUPPL():S428-32. PubMed ID: 993634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.
    Gombert ME; Aulicino TM
    Antimicrob Agents Chemother; 1983 Nov; 24(5):810-1. PubMed ID: 6362558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin treatment of Serratia septicemia in critically ill patients.
    Mosquera JM; de Villota ED; de la Serna JL; Diez-Balda V; Tomás MI; Galdos P; Rubio JJ
    Crit Care Med; 1981 Sep; 9(9):633-6. PubMed ID: 7023839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.